RLMD
Relmada Therapeutics, Inc.
$6.21
-0.24 (-3.72%)
At close · Jul 14
Market Cap
$648.22M
Shares
104,890,223
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-05-28 | 2026-05-27 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| DEF 14A | 2026-04-17 | 2026-05-27 | |
| 8-K | 2026-03-20 | 2026-03-19 | |
| 10-K | 2026-03-19 | 2025-12-31 | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2025-12-15 | 2025-12-12 | |
| 8-K | 2025-11-13 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-05 | 2025-11-04 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-09-17 | — | |
| 8-K | 2025-09-16 | 2025-09-15 | |
| 8-K | 2025-09-10 | — | |
| 8-K | 2025-09-02 | 2025-08-29 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-07-23 | 2025-07-22 | |
| 8-K | 2025-07-10 | 2025-07-07 | |
| 8-K | 2025-06-18 | 2025-06-17 | |
| 8-K | 2025-05-27 | 2025-05-23 | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | 2025-05-08 | |
| 8-K | 2025-04-28 | — | |
| DEF 14A | 2025-04-11 | 2025-05-23 | |
| 8-K | 2025-03-27 | — | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2025-03-26 | 2025-03-24 | |
| 8-K | 2025-02-06 | 2025-02-03 | |
| 8-K | 2025-01-27 | 2025-01-21 | |
| 8-K | 2025-01-06 | 2025-01-01 | |
| 8-K | 2024-12-09 | — | |
| 8-K | 2024-12-04 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-05-30 | 2024-05-24 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| DEF 14A | 2024-04-09 | 2024-05-24 | |
| 8-K | 2024-03-19 | — | |
| 10-K | 2024-03-19 | 2023-12-31 | |
| 8-K | 2024-01-11 | 2024-01-05 | |
| 8-K | 2024-01-04 | — | |
| 8-K | 2024-01-03 | — | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-08 | — | |
| 8-K | 2023-10-11 | — | |
| 8-K | 2023-10-10 | — | |
| 8-K | 2023-10-04 | — |
Showing 1–50 of 116 filings